What To Know About Cobenfy, First New FDA-Approved Treatment For Schizophrenia in Decades
On September 26th, 2024, the FDA announced approval for Cobenfy (xanomeline and trospium chloride) the first novel schizophrenia treatment for adults in over 30 years. Early Cobenfy…
Sep 30, 2024